Tech’s Office of Commercialization Spotlights Nakia Melecio’s Impact on NIH Grant Programs

Nakia Melecio, the VentureLab Principal under the Office of Commercialization, has made remarkable progress in enhancing the grant programs of the National Institutes of Health (NIH). Over an intensive eight-month period, Melecio was part of an evaluation committee that focused on refining initiatives of the NIH’s National Cancer Institute, particularly the Small Business Transition Grant and other related grant programs.

“The experience was both enlightening and challenging,” Melecio said. “We engaged with faculty from over 20 universities to understand the diverse needs — from early-stage research to the commercialization of technology.” His pivotal role in streamlining the application processes for the Small Business Innovation Research and Small Business Technology Transfer programs has significantly enhanced their efficiency and accessibility.

A key aspect of Melecio’s efforts was to increase participation from historically underrepresented groups, with a significant focus on supporting historically Black colleges and universities and minority-serving institutions. His strategic insights have helped reshape these programs to better facilitate the commercialization of technologies developed within academic institutions.

Keith McGreggor, director of VentureLab, praised Melecio’s contributions. “Nakia’s work embodies our mission to transform research into viable market opportunities, ensuring broad access and benefit. The approval of the committee’s recommendations by the NCI leadership marks a significant advancement in our ongoing effort to make NIH funding more accessible and effective,” he said.

As these enhancements are implemented, they promise to significantly improve the landscape for commercializing technologies originating from university research, fostering broader innovation and practical application of groundbreaking discoveries.

The Office of Commercialization at Georgia Tech continues to support faculty and researchers as they navigate these improved opportunities, ensuring that the leadership and expertise within our community are directed toward national and global advancements in science and technology.

Stay engaged with the Office of Commercialization for ongoing updates on this and other initiatives.